Join us for a practical session where we'll discuss the nuances of transitioning medical technologies from research into product development and manufacturing. We'll explore the challenges of recognizing the right time to move forward, taking into account the risks associated with premature advancement. Moving too quickly can lead to wasted time and resources, necessitating additional funds, research, and time to market.
This session will shed light on the real-world challenges faced by management teams, who are often compelled to make decisions before the technology is ready to meet stakeholder expectations. We'll address the balance between satisfying upper management and stakeholders and the associated risks.
Throughout the session, we'll delve into practical techniques for identifying and assessing areas of risk, enabling informed decisions on the progression of medical technology. We'll also discuss the implementation of pragmatic plans and processes to mitigate these risks, aiming for a smoother path to market while improving patient outcomes.
Join us for a down-to-earth exploration of the decision-making process in medical technology development, gaining insights into optimizing the path from development to market in today's dynamic landscape.